Page last updated: 2024-08-24

fluorodopa f 18 and ALS - Amyotrophic Lateral Sclerosis

fluorodopa f 18 has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhatt, MH; Calne, DB; Eisen, A; Peppard, R; Snow, BJ; Takahashi, H	1

Other Studies

1 other study(ies) available for fluorodopa f 18 and ALS - Amyotrophic Lateral Sclerosis

Article	Year
Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet (London, England), 1993, Oct-23, Volume: 342, Issue:8878 Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Basal Ganglia; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Middle Aged; Neural Pathways; Receptors, Dopamine; Substantia Nigra; Time Factors; Tomography, Emission-Computed	1993

Article

Year

Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.

Lancet (London, England), 1993, Oct-23, Volume: 342, Issue:8878

Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Basal Ganglia; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Middle Aged; Neural Pathways; Receptors, Dopamine; Substantia Nigra; Time Factors; Tomography, Emission-Computed

1993